Evidence map›Paper›PMID 35655736›Full record

ReviewThe archives of bone and joint surgery2022

Primary and Metastatic Bone Tumors of the Patella: Literature Review and Institutional Experience.

Nelson Merchán, Caleb M Yeung, Jayden Garcia, Joseph H Schwab, Kevin A Raskin, Erik T Newman, Santiago A Lozano-Calderón

Open access · greenAbstract readReview
In one paragraph

Review in The archives of bone and joint surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Nelson MerchánDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Caleb M YeungDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Jayden GarciaDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Joseph H SchwabDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Kevin A RaskinDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Erik T NewmanDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Santiago A Lozano-CalderónDepartment of Orthopaedic Oncology Harvard Medical School, Massachusetts General Hospital Boston MA, USA.
Massachusetts General Hospital · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Patellar tumors are rare but certainly must be considered in the differential diagnosis in patients with knee pain. Diagnosis can be challenging as often patellar neoplasms are confused with benign conditions and their clinical presentation is usually not specific. We performed an institutional and a literature review to determine what are the most common tumors affecting the patella and what is the best management. Methods: This is a case series from our institution including all patients with benign, malignant, and metastatic patellar neoplasms. Charts were reviewed for patient demographics, clinical presentation, pathology characteristics, radiographic classification, and oncologic and functional outcomes. Results: Twenty-four patients were identified; twelve patients had benign lesions, 10 metastatic and 2 primary malignant tumors. Chondroblastoma and Giant Cell Tumor were the most common tumors. Management of benign lesions with intralesional curettage and packing with bone graft or cement demonstrated excellent results with no local recurrence. In terms of malignant tumors, the spectrum of treatment is variable; it could range from medical management alone or in combination with surgical procedures to total patellectomy with reconstruction of the extensor mechanism. Conclusion: Patellar tumors should be part of the differential in patients with chronic knee pain that does not respond to initial conservative interventions. Recurrence rate with intralesional curettage and bone grafting or cement packing is very low and therefore should be the treatment of choice for benign intraosseous neoplasms. Resection with negative margins in malignant neoplasms or bone metastasis decreases local recurrence but only in the former group there is a potential impact in survival.

Indexed as

Knee tumorsMetastatic bone lesionsPatellaPatellar tumorsPrimary bone tumors

Identifiers

PMID35655736
PMCPMC9117905
OpenAlexW3197956892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.